The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said today at a Senate Health, Education, Labor and Pensions Committee hearing. "This has to be an evidence-based approach — getting the medical therapeutics, vaccines, remdesivir, whichever it happens to be, to the people in need," Hahn said. 

The committee posed questions around reopening, testing and vaccines. Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, M.D., said that communities that disregard "the checkpoints that we put in our guidelines about when it is safe to proceed in pulling back on mitigation" may "trigger an outbreak that you may not be able to control." Nursing home and long-term care facility testing and data reporting also were discussed.

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…